Studies have shown that integrating methylation markers into ctDNA, such as SFRP1, SFRP2, SDC2, and PRIMA1, significantly improves the diagnostic accuracy for CRC, with some cases exhibiting sensitivities exceeding 90% (24). This evidence concerns the gene SFRP2 and colorectal carcinoma.